Psychiatry and Mental Health

I am trained in adult psychiatry. My approach assumes that there are multiple intersecting ways to understand people, including (but not limited to) biological, developmental, situational, and spiritual. These have a blending, and dynamic, influence on our experience and sense of meaning. My aim in working with students is to consider this plurality in order to understand the origin of one’s distress and to develop a path forward. In another universe, I would probably be either the shortstop for the New York Yankees or a behavioral economist. Since I lack the aptitude to do either, I will keep trying my best as a physician.

Professor Killaspy is a clinical academic working in the field of rehabilitation psychiatry. Her research has provided crucial evidence for the effectiveness of specialist services for people with complex mental health needs. She has played a key role in ensuring this evidence is included in policy to support ongoing investment in mental health rehabilitation services in the UK and abroad. She was the Topic Adviser for the first NICE (National Institute for Health and Care) Clinical Guideline on Mental Health Rehabilitation Services(CG 181, NICE, 2020) that provides evidence based recommendations for commissioners to invest in local rehabilitation services, and for service providers about the specific treatments, interventions and support that they should provide to people with complex psychosis.

Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Visiting Professor in the School of Medical Imaging, Jiangsu Vocational College of Medicine, Yancheng 224005 Jiangsu, China, and collaborating for research work with the Centre for Molecular Biophysics from Centre National de la Recherche Scientifique, CNRS, at Orleans, 45071 Orleans, France. He was Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California 92103, U.S.A. He has worked as Scientist in different French and U.S. Research Institutions and Companies. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry; M.S. in Molecular Biology; Ph.D. in Macromolecular Physical Chemistry; Ph.D. in Physical Sciences (Doctorat d’Etat es Sciences Physiques). He is author and co-author of numerous publications and holder of many patents. He is listed in Who’s Who in the World; Who’s Who in America; Who’s Who in Science and Engineering; Who’s Who in Medicine and Healthcare. He is member of different academic organizations such as American Society for Microbiology; American Chemical Society. He is Editor-in-Chief of different scientific journals such as Current Pediatric Research; Enliven: Journal of Genetics, Molecular and Cellular Biology; Journal of Brain Research; etc. He is Editorial Board Member of different scientific journals such as Metabolic Brain Disease; Journal of Pediatric Genetics; Expert Opinion on Orphan Drugs; etc. He is also Invited Reviewer of different scientific journals such as Molecular Genetics and Metabolism; AGE: Journal of the American Aging Association; Journal of Neural Transmission; etc. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). 

Helen Herrman is Professor Emeritus of Psychiatry at Orygen and the Centre for Youth Mental Health, The University of Melbourne, and Director of the World Health Organization (WHO) Collaborating Centre in Mental Health, Melbourne. She is appointed an Officer of the Order of Australia.

Her research and development interests as psychiatrist and public health physician include promoting mental health, community mental health care, and women’s mental health. Previously she was Professor and Director of Psychiatry in St. Vincent’s Health Melbourne, and for a year acted as regional advisor in mental health for the WHO’s Western Pacific Region.

Veerle Bergink is Director of the Womens Mental health Center and tenured Professor at the department of Psychiatry at the Icahn School of Medicine at Mount Sinai. She is internationally recognized as an expert in the treatment of psychiatric disorders during pregnancy and the postpartum period with a specific interest in bipolar disorder. Dr. Bergink established a prospective postpartum psychosis study in 2008, currently the largest first-onset postpartum psychosis and mania cohort in the world. She has defined a highly effective clinical treatment algorithm for treatment of the acute phase and for the prevention of postpartum relapse. Moreover, her research has provided intriguing evidence for an underlying immunological pathophysiology of postpartum depression, mania, and psychosis. She is leading epidemiological studies and clinical cohort studies and she is the principle investigator on multiple research projects including studies on medication use during pregnancy, neuroimaging of new mothers and their offspring, and the longitudinal course of severe perinatal mood disorders. Work from her group has been consistently funded over the 10 years by large grants from the CDC, the National Institute of Mental Health (NIMH) and the European Union. She has won multiple prestigious prizes and has published extensively in top-tier journals.